Facebook-f Twitter Tiktok Instagram Youtube
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
MRKR — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.12

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

0.04

EPS Last/This Y

0.24

EPS This/Next Y

0.38

Price

1.42

Target Price

7.87

Analyst Recom

1

Performance Q

-4.76

Upside

-722.1%

Beta

1.43

Ticker: MRKR



22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-23MRKR1.45N/AN/A0
2026-04-24MRKR1.425N/AN/A0
2026-04-27MRKR1.455N/AN/A0
2026-04-28MRKR1.43N/AN/A0
2026-04-29MRKR1.45N/AN/A0
2026-04-30MRKR1.48N/AN/A0
2026-05-01MRKR1.47N/AN/A0
2026-05-04MRKR1.5501N/AN/A0
2026-05-05MRKR1.51N/AN/A0
2026-05-06MRKR1.47N/AN/A0
2026-05-07MRKR1.45N/AN/A0
2026-05-08MRKR1.46N/AN/A0
2026-05-11MRKR1.45N/AN/A0
2026-05-12MRKR1.45N/AN/A0
2026-05-13MRKR1.45N/AN/A0
2026-05-14MRKR1.47N/AN/A0
2026-05-15MRKR1.43N/AN/A0
2026-05-18MRKR1.4006N/AN/A0
2026-05-19MRKR1.405N/AN/A0
2026-05-20MRKR1.41N/AN/A0
2026-05-21MRKR1.44N/AN/A0
2026-05-22MRKR1.41N/AN/A0
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1



21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-23MRKR1.45- - -0.61
2026-04-24MRKR1.41- - -0.61
2026-04-27MRKR1.49- - -0.61
2026-04-28MRKR1.42- - -0.61
2026-04-30MRKR1.48- - -0.61
2026-05-01MRKR1.47- - -0.61
2026-05-04MRKR1.59- - -0.61
2026-05-05MRKR1.50- - -0.61
2026-05-06MRKR1.46- - -0.61
2026-05-07MRKR1.45- - -0.61
2026-05-08MRKR1.46- - -0.61
2026-05-11MRKR1.47- - -0.61
2026-05-12MRKR1.45- - -0.61
2026-05-13MRKR1.45- - -0.61
2026-05-14MRKR1.46- - -0.61
2026-05-15MRKR1.44- - -0.61
2026-05-18MRKR1.40- - -0.61
2026-05-19MRKR1.41- - -0.61
2026-05-20MRKR1.42- - -0.61
2026-05-21MRKR1.43- - -0.61
2026-05-22MRKR1.4244.8- -0.55
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1



22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-23MRKR0.004.573.78
2026-04-24MRKR0.004.573.78
2026-04-27MRKR0.004.571.41
2026-04-28MRKR0.004.571.41
2026-04-29MRKR0.004.571.41
2026-04-30MRKR0.004.571.41
2026-05-01MRKR0.004.571.41
2026-05-04MRKR0.004.571.41
2026-05-05MRKR0.004.571.41
2026-05-06MRKR0.004.571.41
2026-05-07MRKR0.004.571.41
2026-05-08MRKR0.004.571.41
2026-05-11MRKR0.004.451.41
2026-05-12MRKR0.004.451.12
2026-05-13MRKR0.004.451.12
2026-05-14MRKR0.004.451.12
2026-05-15MRKR0.004.451.12
2026-05-18MRKR0.004.601.12
2026-05-19MRKR0.004.601.12
2026-05-20MRKR0.004.601.12
2026-05-21MRKR0.004.601.12
2026-05-22MRKR0.004.601.12
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS​

-0.16

Avg. EPS Est. Current Quarter

-0.16

Avg. EPS Est. Next Quarter

-0.12

Insider Transactions

Institutional Transactions

4.6

Beta

1.43

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

7

Growth Score

23

Sentiment Score

45

Actual DrawDown %

96.1

Max Drawdown 5-Year %

-98

Target Price

7.87

P/E

Forward P/E

PEG

P/S

7.29

P/B

1.69

P/Free Cash Flow

EPS

-0.67

Average EPS Est. Cur. Y​

-0.55

EPS Next Y. (Est.)

-0.17

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-340.78

Relative Volume

0.55

Return on Equity vs Sector %

-106

Return on Equity vs Industry %

-90.4

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.06

EBIT Estimation

◆ MRKR Healthcare
$1.40
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
19/25
Volume
11/15
Valuation
12/20
TP/AR
4/10
Options
0/10
RSI
44.1
Range 1M
25%
Sup Dist
0.5%
🚀
Momentum Growth
Ride accelerating trends
N/A
19 /100
WEAK
Momentum
1/25
Growth
11/30
Estimates
2/20
Inst/Vol
5/15
Options
0/10
EPS Yr
-21.9%
EPS NY
-5.2%
52W%
18.7%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +462.1% upside
Quality
2/30
Valuation
16/30
Growth
7/25
Stability
7/10
LT Trend
3/5
Upside
+462.1%
Quality
7
Click a card to see score breakdown Full Analysis →
Marker Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 5
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, develops and commercializes T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications in the United States. The company's multi antigen recognizing (MAR)-T cell therapy technology is based on the selective expansion of non-engineered tumor-specific T cells that recognize tumor-associated antigens and kill tumor cells expressing those targets. It develops MT-601, which is in Phase 1 trials for the treatment of lymphoma and pancreatic cancer; and MT-401-OTS, which is in a Phase 1 trial for the treatment of acute myeloid leukemia and myelodysplastic syndromes. The company was formerly known as TapImmune, Inc. and changed its name to Marker Therapeutics, Inc. in October 2018. Marker Therapeutics, Inc. was founded in 1999 and is headquartered in Houston, Texas.
MRKR

Latest News

—
Caricamento notizie per MRKR…
stock quote shares MRKR – Marker Therapeutics Inc Stock Price stock today
news today MRKR – Marker Therapeutics Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch MRKR – Marker Therapeutics Inc yahoo finance google finance
stock history MRKR – Marker Therapeutics Inc invest stock market
stock prices MRKR premarket after hours
ticker MRKR fair value insiders trading